HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The spectrum of phenylketonuria genotypes in the Armenian population: identification of three novel mutant PAH alleles.

Abstract
We present the spectrum of phenylalanine hydroxylase (PAH) gene mutations upon investigating 35 index patients identified with hyperphenylalaninemia in Armenia. One patient was diagnosed with dihydropteridine reductase (DHPR) deficiency, whereas all other 34 and their 6 affected siblings presented with mild or classical phenylketonuria (PKU). By analyzing all 13 exons plus exon-intron boundaries of the PAH gene, we identified two mutant alleles in 23 PKU patients, three mutations in 1, only one mutation in 5, and no mutation in 5 PKU patients. The most prevalent mutation was the well defined splicing error in intron 10, c.1066-11G>A (17/68 alleles). The three alterations, c.836C>T (p.Pro279Leu) in exon 7, c.1129T>G (p.Tyr377Asp) in exon 11, and c.1244A>T (p.Asp415Val) in exon 12, have not been reported in the PAH locus database (http://www.pahdb.mcgill.ca) and, thus, might be specific for the culturally homogenous Armenian population.
AuthorsNatella Kostandyan, Corinne Britschgi, Albert Matevosyan, Alvina Oganezova, Anahit Davtyan, Nenad Blau, Beat Steinmann, Beat Thöny
JournalMolecular genetics and metabolism (Mol Genet Metab) Vol. 104 Suppl Pg. S93-6 ( 2011) ISSN: 1096-7206 [Electronic] United States
PMID21890392 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • Mutant Proteins
  • Phenylalanine Hydroxylase
Topics
  • Alleles
  • Armenia
  • Genotype
  • Humans
  • Mutant Proteins (genetics)
  • Mutation (genetics)
  • Phenylalanine Hydroxylase (genetics)
  • Phenylketonurias (enzymology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: